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57%), and/or surgical procedure(s) for treatment (n= 258, 63%). Among SSIs included 
in the validation, temporally-associated antibiotics, surgical treatment procedures, 
and cultures were present for 84% (338/401), 61% (246/401), and 59% (238/401) respec-
tively. Only 5.7% (23/401) of procedures coded for SSI post-procedure had no antibiot-
ics, surgical treatment, or culture within 14 days of the SSI claim. ConClusions: 
Over 94% percent of patients identified by our claims algorithm as having an SSI 
received clinically expected treatment for infection, including surgery, cultures, and 
antibiotics, suggesting this algorithm has very good positive predictive value. This 
method may facilitate retrospective SSI surveillance and comparison of SSI rates 
across facilities and providers.
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objeCtives: Integrated delivery networks (IDNs) capture patient data across the 
continuum of care and are valuable tools for real-world research, with potential to 
study large, diverse cohorts with rich information on patient characteristics, treat-
ments, physician decisions and outcomes. However, using multiple IDNs requires 
combination of dissimilar data to create a uniform post hoc analysis dataset. We 
used this approach to create a novel cohort to examine maternal and neonatal 
characteristics with the goal of better understanding preterm labor, a critical step 
in developing effective tocolytic treatments. Methods: Retrospective data on 
births from 2001-2012 were collected from 4 U.S. IDNs (from Illinois, Ohio, New 
Mexico and central states [Missouri/Arkansas/Kansas/Oklahoma] participating in 
Quintiles’ COMparative effectiveness PAtient Safety and Surveillance (COMPASS) 
Research Network. The IDNs were geographically/racially distinct with varying types 
of electronic medical records, catchment areas and institution types. Detailed data 
specifications were defined, mothers and babies were linked using medical record 
numbers and files were pooled to produce an overall cohort. Results: A cohort of 
109,583 mother-baby pairs among women with uncomplicated, singleton pregnan-
cies was built each associated with their clinical records. Data were collected on 
maternal medication use and specific pregnancy complications (e.g., eclampsia/
HELLP, placental conditions and infections) and neonatal characteristics including 
demographics, weekly gestational age, procedures, treatments and hospital-based 
clinical outcomes. ConClusions: IDNs offer an in-depth source of real-world data 
to evaluate characteristics of otherwise difficult-to-study populations. However, 
employing routine care information from diverse settings for research presents chal-
lenges and varying definitions, coding processes and facility characteristics should 
be considered before analyses. Processes must be developed to translate clinical 
records into standardized analytic research datasets. Development of detailed speci-
fication and harmonization processes allowed creation of a cohesive and unique 
mother-baby linked data resource that could be extended to a broad range of peri-
natal epidemiology and health outcomes research questions.
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objeCtives: To estimate associations between attributes of COPD and to develop 
a model that predicts economic and health outcomes associated with COPD pro-
gression. Methods: We utilized data from ECLIPSE (clinicaltrials.gov identifier: 
NCT00292552), a three year cohort study of COPD patients to estimate the asso-
ciations between central COPD attributes (exacerbations, lung function, exercise 
capacity, and signs/symptoms) while adjusting for co-morbidities, body composition 
(BMI), biomarkers, smoking history, age, and gender. As disease progression end-
points we used the total score of the St. George’s Respiratory Questionnaire (SGRQ) 
and mortality. We applied random coefficient models to assess the relationships 
between the central COPD attributes longitudinally and thereby describe patient 
trajectories over time. As appropriate, non-linear functional forms were explored 
to characterize the nature of the data. Endogeneity among the central attributes of 
COPD was addressed by time-lagging in the regression models. Results: Severe 
exacerbations in the preceding 12-months were associated with an average decline 
in lung function (FEV1) of up to 10 ml (P< 0.05) and with a reduced exercise capacity 
(6 minute walk test) of 13 meters (P< 0.0001). A 1% increase in FEV1 % predicted was 
also associated with a 5% reduction in the probability of experiencing dyspnoea on 
most days/week (P< 0.0001). All central attributes were found to significantly impact 
disease progression, measured by the SGRQ, with the largest estimated effect for 
dyspnoea on most days/week (18 point increase in the SGRQ score; P< 0.0001). Lung 
function and exercise capacity, however, were the only central attributes that were 
significant predictors of mortality (P< 0.05). ConClusions: The use of appropriate 
analytical techniques to account for the longitudinal nature and endogeneity of 
COPD attributes enables the estimation of their impact on important health out-
comes. Our results confirm the expected associations between the central attributes 
of COPD and their effect on patient health status (SGRQ) and mortality.
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objeCtives: the association between depressive symptoms (Center for 
Epidemiologic Studies Depression Scale [CES-D]) and subsequent cognitive function 
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objeCtives: The 4-item Morisky Medication Adherence Scale (MMAS-4) and more 
recent 8-item version (MMAS-8) have both been validated and demonstrate concur-
rent validity among patients with hypertension, but the extent to which the scales 
can be compared has received little attention. This study assessed the comparabil-
ity of adherence scores obtained with these scales in patients with type 2 diabetes 
(T2D) as well as the feasibility of integrating results across the scales using 4 items 
of the MMAS-8. Methods: Data were taken from the 2011 and 2012 US National 
Health and Wellness Survey (NHWS). The NHWS is a large cross-sectional survey 
representative of the total adult population in several major markets; N~75,000/year 
in the US. A total of 13,007 respondents self-reported physician diagnosis of T2D and 
were administered MMAS-4 in 2011 or MMAS-8 in 2012. The two adherence scales 
were evaluated by comparing the frequency distributions of the MMAS scores for the 
two scales, Cronbach’s alpha and inter-item correlations, and the creation of a new 
4-item scale including the questions in MMAS-8 that best matched the questions 
in MMAS-4. Results: In T2D patients, both MMAS-4 and -8 scores are Poisson-like 
distributed, with median at zero (high adherence) for MMAS-4 and at 1 (medium 
adherence) for MMAS-8. Chronbach’s alpha was 0.55 for MMAS-4 and 0.71 for MMAS-
8, while average item-test correlations were 0.65 and 0.57, respectively. The reduced 
4-item scale created out of MMAS-8 is also Poisson-like distributed, Cronbach’s 
alpha was 0.62 and the average item-test correlation was 0.68. ConClusions: 
Scores of the two MMAS show similar qualitative and quantitative characteristics, 
suggesting that it may be appropriate to integrate data sources using the two dif-
ferent versions, particularly when the responses to the subset of 4 MMAS-8 items 
are available. Future research should confirm that the scales can be integrated in 
different therapeutic areas.
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objeCtives: We aimed to validate the telephone administration of the Revised Pre-
screening Denver Questionnaire (R-PDQ) and the Ages and Stages Questionnaire 
(ASQ), 2 tools used to pre-screen and screen children development, respec-
tively. Methods: The OTIS Antidepressants in Pregnancy Study cohort was used. 
Women were recruited through nine North American Teratogen Information 
Services and at the CHU Ste-Justine outpatient obstetrical clinic (Montreal). To be 
included, women had to be > 18 years old, < 15 weeks pregnant, and not using known 
teratogens. Both questionnaires were self and telephone- administered to mothers 
at 12-months postpartum. The ASQ includes five domains (communication, gross 
motor, fine motor, problem-solving and personal-social). The R-PDQ tests gross 
and fine motor, personal-social and language skills. Socio-demographic variables 
were collected through telephone interviews. Concordance between the telephone 
and self-administration of both questionnaires were assessed with Intraclass 
Correlation Coefficients (ICC) with 95% Confidence Intervals (CI). Results: Overall, 
61 and 56 women filled the ASQ and R-PDQ, respectively. Concordance between the 
self and telephone-administered ASQ was substantial for the communication scale 
(ICC= 0.76;95% CI (0.63;0.84)), almost perfect for the gross motor scale (ICC = 0.83; 95% 
CI (0.73; 0.90), and moderate for the fine motor, problem-solving and personal-social 
scales (ICC = 0.44; 95% CI (0.21; 0.62); ICC = 0.43; 95% CI (0.19; 0.61); ICC = 0.52; 95% CI 
(0.31; 0.68); respectively). Regarding the R-PDQ, the following concordance estimates 
were found: gross motor scale (ICC = 0.90; 95% CI (0.83; 0.94)), language (ICC = 0.58; 
95% CI (0.38; 0.72), personal-social scales (ICC = 0.27; 95% CI (0.07; 0.49). The agree-
ment was perfect for the fine motor scale. ConClusions: The telephone admin-
istration of the ASQ is a valid method of child development screening. However, 
only the R-PDQ gross and fine motor and language scales should be administered 
through telephone when pre-screening infant development.
PRM13
valiDation of claiMs Data to iDentify suRgical site infections with 
antibiotic utilization Data***
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objeCtives: International Classification of Diseases (ICD-9-CM) diagnosis codes are 
increasingly being used to identify hospital-acquired infections, often with insuffi-
cient evidence demonstrating validity of the codes used. Absent medical record veri-
fication, we sought to confirm a claims algorithm to identify surgical site infections 
(SSI) by determining the presence of clinically expected SSI treatment. Methods: 
We performed a retrospective cohort study using private insurer claims data from 
persons < 65 years with ICD-9-CM procedure or CPT-4 codes for anterior cruciate 
ligament (ACL) reconstruction from 1/2004–12/2010. SSIs occurring within 90 days 
after ACL reconstruction were identified by ICD-9-CM diagnosis codes. Antibiotic 
utilization, surgical treatment, and microbiology culture claims within 14 days of SSI 
codes were used for validation. Results: Of 40,702 ACL reconstruction procedures, 
409 (1.0%) were complicated by SSIs, 172 (0.4%) of which were specifically identified 
as septic arthritis. Most SSIs were associated with an inpatient admission (n= 232, 
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objeCtives: Many medical and epidemiological research studies are based 
on observational data. In this study, we compare three different propensity 
scores: unadjusted propensity score (UPS), prognostic propensity score 1(PPS1), 
and prognostic propensity score 2(PPS2) using the inverse probability weighted 
(IPW) estimator for assessing patient reported outcomes (PROs) in terms of 
average treatment effect (ATE) and average treatment effect on the treated 
(ATT). Methods: We conducted a Monte Carlo simulation study to evaluate these 
three propensity scores for estimating ATE and ATT in terms of bias, mean squared 
error (MSE), and coverage probability (CP). Results: The simulation results show 
that PPS1 has the poorest performance compared to UPS and PPS2 in terms of bias, 
MSE and CP. ConClusions: Based on these simulation results, we recommend 
using UPS and PP2 for estimating ATE and ATT for patient reported outcomes in 
practice.
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objeCtives: To identify proportion of radiology Health care professionals’ opinions 
regarding level of difficulty in conducting research in radiology and to ascertain bar-
riers associated in conducting research activities in field of radiology. Methods: 
Cross-sectional analytical study was conducted during International Conference 
organized by Radiological Society of Pakistan in November 2009 at Sheraton Hotel, 
Karachi. Data were collected using a structured, self-administered questionnaire 
from participants willing to participate in research registered for Annual Radiology 
Research Workshop piloted during conference; via non-probability convenience 
technique. Data were analyzed using SPSS versions 19.0.Means±SD were computed 
for quantitative and proportions calculated for qualitative variables. Chi square 
and Fisher Exact tests applied for categorical variables. A p-value of < 0.001 was 
considered significant. Results: Response rate was 76% (n= 78/103), 65.4% agreed 
that conducting research in the field of radiology is difficult. Most of the participants 
(69.2%) who had not published papers believed that research in radiology is difficult 
as compared to those who had published a paper (30.8%) (p= 0.026). However, age, 
sex, attending conferences and presenting papers did not significantly influence 
response of participants. The top three barriers in conducting research in field of 
radiology were time required to provide clinical services (92.3%), lack of dedicated 
time for research (91.0%) and diminished income in research (88.5%). Although 
similar responses were observed among residents and consultants regarding bar-
riers in conducting research, more residents than consultants believed that lack of 
support from dean (p= 0.037) and diminished income in research activities (p= 0.003) 
were significant barriers. ConClusions: Most of the participants’ opinion was 
that conducting research in field of radiology is difficult. Time required providing 
clinical services, lack of dedicated time for research, diminished income in research 
activities were identified as most important barriers in conducting research. Similar 
responses were observed among residents and consultants regarding barriers in 
conducting research.
PRM21
views of health caRe PRoviDeRs on MeDical eRRoRs in kaRachi, 
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objeCtives: Incidence of medical errors is an area of concern for health care 
providers and policy makers. The large number of preventable errors, risk of 
litigations, patients’ insecurity and lack of confidence in health care provision 
is a concern globally. In an underdeveloped country like Pakistan, patient safety 
is an important trepidation as it poses a great cost burden on health care sys-
tem. Objectives of this cross-sectional analytical study are, to estimate the rate 
of medical errors and to assess the factors that influence medical error report-
ing in Pakistan. Methods: Data were collected over period of three months, via 
self-administered survey questionnaire. 385 participants, including doctors, 
nurses and paramedics from different private and government hospitals of 
Karachi were selected by non-probability convenience sampling technique. 
Questionnaire elicited information about number of errors witnessed and 
reported, by health care providers and factors that influence error-reporting, 
after an informed consent. Results: According to the preliminary review of 
data, approximately 90 percent of health care professional believe that medical 
errors are common. More than 50 percent have witnessed medical errors. 80 per-
cent of the population surveyed has experienced a medical error. Approximately 
half of the participants believe that medical errors are not often reported in our 
country. ConClusions: Though a substantial number of the health care profes-
sionals in Karachi have ever witnessed or experienced a medical error, majority 
is of the opinion that not many are reported or disclosed. Improving health care 
system for patient safety is need of the hour. Both management and health care 
professionals need to improve error-reporting systems in Pakistan so as to check 
the cost burden on health care.
ReseaRch on MethoDs – cost Methods
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objeCtives: Although a number of studies have been conducted to estimate the 
economic implications of comorbid obesity in diabetic patients, mixed conclu-
(Mini-Mental State Examination [MMSE]) is equivocal in literature. To examine the 
association between them, we use longitudinal data on MMSE and CESD and causal 
inference to illustrate the relationship between two health outcomes. Methods: 
Data were obtained from the Hispanic Established Populations for Epidemiologic 
Studies of the Elderly. Participants included 3050 noninstitutionalized Mexican 
Americans aged 65 and older followed from 1993-2001. Cognitive function and 
depressive symptoms were assessed using the MMSE and CESD at baseline and at 
2, 5, and 7 years of follow-up. Independent variables were sociodemographics, CESD, 
medical conditions. Marginal structural causal models were employed to evaluate 
the extent to which cognitive function depend not only on depressive symptoms 
measured at a single point in time but also on an individual’s entire depressive 
symptoms history. Results: our results indicate that if intervention to reduce 1 
points of depressive symptoms were made at two years prior to assessing cognitive 
function, they would result in average improvement in cognitive function of 0.11, 
95% CI [0.05, 0.16],P< .0001. ConClusions: The results suggest that health inter-
vention of depressive symptoms would be useful in prevention of cognitive impair.
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MethoDs foR evaluating the effect MoDification in the 
obseRvational stuDies: a RetRosPective analysis on the iMPact 
of siMvastatina anD ezetiMibe anD statins on acute MyocaRDial 
infaRction
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objeCtives: Fundamental potential weaknesses of observational studies are:bias 
and effect modification. In this situation, computing an overall estimate of asso-
ciation is misleading. The aim was to compare a traditional multivariable-adjusted 
model with a propensity score (PS) model and a cluster analysis (CA) model, in esti-
mating the association between type of lipid modifying agent and hospitalization 
for Acute Myocardial Infarction (AMI). Methods: The Health Register of Emilia-
Romagna (Italy; more than 10 Million records; 4.4 Milion Inhabitants) was used to 
select between January 1st, 2006 and December 31st, 2011 Statins and Simvastatin 
and Ezetimibe (SE) naïve users. A PS was constructed, predicting treatment assign-
ment from age, gender, use of diabetic agents, different pharmacologic agents, 
comorbidity level and utilization of outpatient services. For analysis’ purpose, the 
effect of the treatment on the risk of IMA was measured by estimates of hazard 
rations (HR) in different fashions using: multivariable Cox regression model (CRM), 
CRM adjusted for the PS, CRM model within each cluster identified by a K-means 
method. Results: Over 2,6 Mil inhabitants (+40 years) 57,902 (92.2%) patients were 
naïve statin users and 4,904 (7.8%) were SE users. Compared with Statins, the risk of 
IMA for SE resulted similar in the adjusted CRM and in the propensity CRM (HR= 1.47 
and HR= 1.49 respectively). While the CRMs performed within each cluster yielded 
different treatment effect estimates (HR= 2.39 for Cluster 1; HR= 1.36 for Cluster 2; 
1.37 for Cluster 3). ConClusions: The CA allowed to identify specific subgroups 
of patients, with homogeneous risk features. The CRM within each cluster yielded 
different treatment effect estimates that might suggest the presence of unmeasured 
confounding. In that case, traditional regression model and PS developed using 
administrative data do not necessarily balance patient characteristics contained 
in clinical data. Choice among different approaches for investigating effect modi-
fication should be sensitive to the circumstances of the data analysis in applying 
observational studies.
PRM18
Multi-cRiteRia Decision analysis in oncology: an oveRview
Adunlin G.1, Diaby V.1, Montero A.2, Xiao H.1
1Florida A&M University, Tallahassee, FL, USA, 2Cleveland Clinic, Clevland, OH, USA
objeCtives: Diagnosis, treatment, and management decisions in oncology can 
be particularly difficult, involving a complex web of diagnostic and therapeutic 
uncertainties, patients’ preferences and value, as well as costs. These decisions 
involve trade-offs between possible benefits and harms. There is growing interest 
in the development and application of alternative decision-making frameworks 
within oncology, including multi-criteria decision analysis (MCDA). Even though 
the literature includes several reviews on MCDA methods, applications of MCDA 
in oncology are lacking. This study sought to discuss the rationale for using MCDA 
in oncology. In this context, the following research question emerged: How can 
MCDA be used to develop a clinical decision support tool in oncology? Methods: 
This study surveyed several applications of MCDA in the field of oncology. In par-
ticular, the study reviewed key contributions addressing screening and treatment 
decision-making in this area. It proposed research opportunities in the context 
of oncology, and presented a hypothetical scenario to show how MCDA could be 
applied in oncology. Results: The literature review identified eight studies. Five 
studies examined decision making for cancer screening. Four studies demonstrated 
applicability and acceptability of the Analytic Hierarchy Process (AHP) as a means to 
involve patients in oncology decisions and translate evidence into clinical practice. 
The study showed that a wide range of MCDA methods exist; each has its strengths 
and weaknesses. Choosing the appropriate method vary depending on the source 
and nature of information used to inform decision-making. ConClusions: Given 
recent policy movements toward evidence-based decisions, multidisciplinary teams, 
and shared decision-making, the field of oncology will continuously seek ways to 
make comprehensive and transparent decisions. MCDA appears to be a promising 
tool to assist clinical decision-making in oncology and help assess trade-offs regard-
ing preferences. Nonetheless, field-testing is desirable before MCDA becomes an 
established decision-making tool in oncology.
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